Glenmark Pharmaceuticals Inc., USA (Glenmark) announces the launch of Epinephrine Injection USP, 10 mg/10 mL (1 mg/mL) Multiple-Dose Vial. Glenmark's Epinephrine Injection USP, 10 mg/10 mL (1 mg/mL) ...

Glenmark Pharmaceuticals has launched a generic version of Epinephrine injection multiple-dose vial in the US, gaining 180 days of CGT exclusivity. The injection treats hypotension from septic shock ...

Mahwah: Glenmark Pharmaceuticals Inc., USA has announced the launch of Epinephrine Injection USP, 10 mg/10 mL (1 mg/mL) ...

Glenmark Pharma announced that its US-based subsidiary, Glenmark Pharmaceuticals Inc, has launched the Epinephrine Injection USP, 10 mg/10 mL (1 mg/mL) multiple-dose vial.

Glenmark Pharma launches epinephrine injection USP, 10 mg/10 mL (1 mg/mL) multiple-dose vial: Our Bureau, Mumbai Thursday, February 27, 2025, 12:30 Hrs [IST] Glenmark Pharmaceutic ...

According to a company statement, Glenmark Pharmaceuticals Inc., USA, an arm of the company, has launched the Epinephrine injection of strength 10 mg/10 mL (1 mg/mL) multiple-dose vial.

This launch of Epinephrine Injection USP, 10 mg/10 mL (1 mg/mL) Multiple-Dose Vial is eligible for 180 days of CGT exclusivity under section 505(j)(5)(B)(v) of the FD&C Act, it added. According to ...

In South Africa, it would be easier for taxpayers to comply if we were to seek locally appropriate solutions and make a conscious effort to keep every amendment as simple as possible. The fiscus would ...

Zhejiang Doer Biologics Co., Ltd. ("Doer Bio"), a clinical stage biopharmaceutical company developing innovative biotherapeutics for metabolic diseases and cancers, today announces that DR10624, its ...

In recent months it seems like every major dealer group has been taking an axe to its dealer network in one way or another.